s-methylisothiopseudouronium has been researched along with Disease Exacerbation in 2 studies
S-methylisothiopseudouronium: inhibits nitric oxide synthase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leung, TM | 1 |
| Tipoe, GL | 1 |
| Liong, EC | 1 |
| Lau, TY | 1 |
| Fung, ML | 1 |
| Nanji, AA | 1 |
| Nakanishi, H | 1 |
| Zhang, J | 1 |
| Koike, M | 1 |
| Nishioku, T | 1 |
| Okamoto, Y | 1 |
| Kominami, E | 1 |
| von Figura, K | 1 |
| Peters, C | 1 |
| Yamamoto, K | 1 |
| Saftig, P | 1 |
| Uchiyama, Y | 1 |
2 other studies available for s-methylisothiopseudouronium and Disease Exacerbation
| Article | Year |
|---|---|
Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis.
Topics: Alanine Transaminase; Animals; Arginine; Blotting, Western; Carbon Tetrachloride; Chronic Disease; D | 2008 |
Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice.
Topics: Animals; Apoptosis; Body Weight; Cathepsin D; Cell Count; Disease Progression; Drug Administration S | 2001 |